Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment.

PropertyValue
has major subject area list Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Chemotherapy, Adjuvant; Deoxycytidine; Gene Expression Regulation, Neoplastic; Pancreatic Neoplasms
information resource reference Ushida Y, Inoue Y, Ito H, Oba A, Mise Y, Ono Y, Sato T, Saiura A, Takahashi Y. High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment. Pancreatology. 2021 Jan; 21(1):130-137.
label High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment.

Search Criteria
  • Pancreatic Cancer

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)